secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIMEDX GROUP, INC. (MDXG)
CIK:        0001376339
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001193125-23-266161
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiMedx Q3 net sales up 20.7% to $81.7M, GAAP net income $8.5M, raises FY outlook
--------------------------------------------------------------------------------

- Q3 net sales $81.7M (+20.7% YoY); GAAP net income $8.5M vs loss $8.4M prior year.
- Adjusted EBITDA $17.6M (21.6% margin) vs $2.4M; cash from ops $12.8M.
- Raised FY2023 net sales growth outlook to high teens; expects H2 Adj. EBITDA margin >20%.
- Repurchased $9.5M of Series B Preferred Stock from Hayfin; one-year lock-up.
- Cash $81.2M, up from $66.0M at Dec 31, 2022; long-term debt $49.0M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1376339/000119312523266161/0001193125-23-266161-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1376339/000119312523266161/d570687d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-266161

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer